ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
NexGel Inc

NexGel Inc (NXGL)

2.21
-0.045
(-2.00%)
Closed April 19 4:00PM
2.21
0.00
(0.00%)
After Hours: 4:30PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.21
Bid
2.09
Ask
2.41
Volume
1,052
2.21 Day's Range 2.24
1.3201 52 Week Range 3.14
Market Cap
Previous Close
2.255
Open
2.24
Last Trade
11
@
2.205
Last Trade Time
Financial Volume
$ 2,325
VWAP
2.21
Average Volume (3m)
23,692
Shares Outstanding
5,717,629
Dividend Yield
-
PE Ratio
-2.66
Earnings Per Share (EPS)
-0.83
Revenue
2.05M
Net Profit
-4.75M

About NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels a... NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company recognizes revenue from contract manufacturing. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
NexGel Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NXGL. The last closing price for NexGel was $2.26. Over the last year, NexGel shares have traded in a share price range of $ 1.3201 to $ 3.14.

NexGel currently has 5,717,629 shares outstanding. The market capitalization of NexGel is $12.64 million. NexGel has a price to earnings ratio (PE ratio) of -2.66.

NXGL Latest News

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024

LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

LANGHORNE, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for...

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.062.790697674422.152.2551.98122972.18003293CS
4-0.49-18.14814814812.72.851.98209442.34112476CS
12-0.08-3.493449781662.293.141.98236922.53166361CS
260.2814.50777202071.933.141.46217302.27387785CS
520.7147.33333333331.53.141.3201375172.30297055CS
156-2.19-49.77272727274.44.661.09781312.54370499CS
260-2.19-49.77272727274.44.661.09781312.54370499CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AGBAAGBA Group Holding Ltd
$ 1.03
(157.50%)
122.88M
ISPCiSpecimen Inc
$ 0.44
(106.57%)
37.44M
XPONExpion360 Inc
$ 3.12
(61.66%)
16.63M
BNTCBenitec Biopharma Limited
$ 6.99
(45.63%)
3.51M
TIRXTian Ruixiang Holdings Ltd
$ 0.70
(44.40%)
58.67M
WISAWiSA Technologies Inc
$ 5.89
(-36.32%)
16.09M
SPCBSuperCom Ltd
$ 0.24
(-33.31%)
8.57M
EDBLEdible Garden AG Inc
$ 4.52
(-32.13%)
698.17k
MRNOMurano Global Investments PLC
$ 7.22
(-31.24%)
123.91k
AILEiLearningEngines Holdings Inc
$ 7.11
(-28.90%)
53.08k
SINTSiNtx Technologies Inc
$ 0.0396
(6.17%)
438.98M
SQQQProShares UltraPro Short QQQ
$ 12.07
(1.77%)
172.66M
AGBAAGBA Group Holding Ltd
$ 1.02
(155.00%)
122.88M
GGEGreen Giant Inc
$ 0.0362
(23.76%)
96.91M
TSLATesla Inc
$ 149.93
(-3.55%)
96.1M

NXGL Discussion

View Posts
tdag910 tdag910 1 month ago
Winner winner chicken dinner!!
👍️0
Pinksatthehotel Pinksatthehotel 1 month ago
Looking good!
👍️0
tdag910 tdag910 5 months ago
Anybody home?
👍️0
alyck alyck 11 months ago
NXGL looking great! Solidly over $2 and volume increasing. Keep it going
👍️0
81vette 81vette 11 months ago
Ended @New 52 week high,blue sky babe!! Enjoy the weekend everyone!!
👍️0
81vette 81vette 11 months ago
contracts with pro sports teams will make brand huge,building a great company,investment in packaging plant was wise
👍️0
81vette 81vette 11 months ago
For the first quarter of 2023, revenue totaled $620 thousand and increased by $224 thousand, or 56.6%, compared to $396 thousand for the same period the year prior. The increase in overall revenues was primarily due to sales growth in both contract manufacturing and branded products. Revenue during the first quarter of 2023 includes one full month of revenue contribution from the Company’s newly formed joint venture with C.G. Laboratories.first quarter we delivered 56.6% revenue growth year-over-year, driven by increased sales in contract manufacturing and branded consumer products. We also started to see contribution in March from our new joint venture with CG Labs. During the quarter, we launched several new products and invested strategically in sales and marketing to support those launches. We are already starting to see the financial returns from these investments in the second quarter, as well as from our new JV.” “Based on the dynamic changes to our business, which include the March 1 joint venture, I feel it’s important to provide a one-time exception to our policy of not providing guidance. Based on these developments and our progress to date, we are projecting $1.0 million in revenue for the second quarter of 2023, an increase of 78.2% year-over-year. Complementing this, we had approximately $5.8 million in cash and cash equivalents at quarter-end, which gives us sufficient runway to operate and the ability to be opportunistic about further potential investments to accelerate our growth.”Acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business.
Executed a supply agreement with a large new customer relating to a new consumer product.Launched advertising and marketing initiative, which has increased branded product sales.
👍️ 1
81vette 81vette 11 months ago
watch demand,next move up thru 52 week high,very low supply atm
👍️0
81vette 81vette 11 months ago
GOLDEN CROSS is best indicator of long bulls,follow the money is the saying
👍️0
81vette 81vette 11 months ago
eps q/q up 60%,is why moving up,big profit coming,great future $ deals,expect institutions loading long,way undervalued@ 10M mkt cap
👍️0
81vette 81vette 11 months ago
GOLDEN CROSS now,thru triple top res.,52week high>$2.00,then blue sky
👍️0
81vette 81vette 11 months ago
4M float,5M o/s,.52%short,buy vol 15X ave,not optionable,shares borrow ava. dropped 400% with pre-mkt volume,easily could go ZERO BORROW with this low float/os
👍️0

Your Recent History

Delayed Upgrade Clock